A61K 40/4223
Cd44 not igg
Official title: {CD44 not IgG}
A61K40/4223 (Cd44 not igg) appears on 8 US grants and 26 published applications in this corpus.
Search patents in A61K- Granted patents
- 8
- Published applications
- 26
- Assignees
- 17
- Inventors
- 48
- Latest grant
- 18 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 2 | 2 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 3 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 3 |
| 2022 | 1 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 6 |
| 2025 | 0 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Chimeric antigen receptors and methods for reducing toxicity18 Jul 2023US 11,701,405 B2City of Hope
- Chimeric antigen receptors12 Apr 2022US 11,299,529 B2AGC Biologics S.p.A.
- Compositions and methods for treatment of neoplastic disease6 Oct 2015US 9,149,504 B2
- Cancer stem cell antigen vaccines and methods5 May 2015US 9,023,338 B2Cedars-Sinai Medical Center
- Compositions and methods for treatment of neoplastic disease3 Sep 2013US 8,524,218 B2
- Cell membrane-attached hyaluronic acid-cd44 specific binding reaction polymer compound to enhance the immune-anticancer function of natural killer cells12 Feb 2026US 2026/0041770 A1Dongguk University Industry-Academic Cooperation Foundation
- Anti-glyco-cd44 antibodies and their uses23 Oct 2025US 2025/0326855 A1GO Therapeutics, Inc.
- Combination of a glycosylation inhibitor with one car cell therapy for treating cancer10 Apr 2025US 2025/0114386 A1Fondazione Centro San Raffaele
- Natural killer cell-specific chimeric antigen receptor and use thereof9 Jan 2025US 2025/0009879 A1The Asan Foundation
- Compositions and methods for immunotherapy27 Jun 2024US 2024/0207319 A1Ludwig Institute for Cancer Research
Most cited
By later US patents